These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 10234506)
21. Association between centromeric deletions of the SMN gene and sporadic adult-onset lower motor neuron disease. Moulard B; Salachas F; Chassande B; Briolotti V; Meininger V; Malafosse A; Camu W Ann Neurol; 1998 May; 43(5):640-4. PubMed ID: 9585359 [TBL] [Abstract][Full Text] [Related]
22. A novel association of the SMN protein with two major non-ribosomal nucleolar proteins and its implication in spinal muscular atrophy. Lefebvre S; Burlet P; Viollet L; Bertrandy S; Huber C; Belser C; Munnich A Hum Mol Genet; 2002 May; 11(9):1017-27. PubMed ID: 11978761 [TBL] [Abstract][Full Text] [Related]
23. A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy. Monani UR; Pastore MT; Gavrilina TO; Jablonka S; Le TT; Andreassi C; DiCocco JM; Lorson C; Androphy EJ; Sendtner M; Podell M; Burghes AH J Cell Biol; 2003 Jan; 160(1):41-52. PubMed ID: 12515823 [TBL] [Abstract][Full Text] [Related]
24. Identification and characterization of the porcine (Sus scrofa) survival motor neuron (SMN1) gene: an animal model for therapeutic studies. Lorson MA; Spate LD; Prather RS; Lorson CL Dev Dyn; 2008 Aug; 237(8):2268-78. PubMed ID: 18651653 [TBL] [Abstract][Full Text] [Related]
25. Therapeutics development for spinal muscular atrophy. Sumner CJ NeuroRx; 2006 Apr; 3(2):235-45. PubMed ID: 16554261 [TBL] [Abstract][Full Text] [Related]
26. Correlation between severity and SMN protein level in spinal muscular atrophy. Lefebvre S; Burlet P; Liu Q; Bertrandy S; Clermont O; Munnich A; Dreyfuss G; Melki J Nat Genet; 1997 Jul; 16(3):265-9. PubMed ID: 9207792 [TBL] [Abstract][Full Text] [Related]
27. Premature termination mutations in exon 3 of the SMN1 gene are associated with exon skipping and a relatively mild SMA phenotype. Sossi V; Giuli A; Vitali T; Tiziano F; Mirabella M; Antonelli A; Neri G; Brahe C Eur J Hum Genet; 2001 Feb; 9(2):113-20. PubMed ID: 11313744 [TBL] [Abstract][Full Text] [Related]
28. Characterization of survival motor neuron (SMNT) gene deletions in asymptomatic carriers of spinal muscular atrophy. Wang CH; Xu J; Carter TA; Ross BM; Dominski MK; Bellcross CA; Penchaszadeh GK; Munsat TL; Gilliam TC Hum Mol Genet; 1996 Mar; 5(3):359-65. PubMed ID: 8852661 [TBL] [Abstract][Full Text] [Related]
29. Correlation between deletion patterns of SMN and NAIP genes and the clinical features of spinal muscular atrophy in Indian patients. Dastur RS; Gaitonde PS; Khadilkar SV; Udani VP; Nadkarni JJ Neurol India; 2006 Sep; 54(3):255-9. PubMed ID: 16936383 [TBL] [Abstract][Full Text] [Related]
30. Duplications and de novo deletions of the SMNt gene demonstrated by fluorescence-based carrier testing for spinal muscular atrophy. Chen KL; Wang YL; Rennert H; Joshi I; Mills JK; Leonard DG; Wilson RB Am J Med Genet; 1999 Aug; 85(5):463-9. PubMed ID: 10405443 [TBL] [Abstract][Full Text] [Related]
31. Deletion of SMN and NAIP genes in Korean patients with spinal muscular atrophy. Shin S; Park SS; Hwang YS; Lee KW; Chung SG; Lee YJ; Park MH J Korean Med Sci; 2000 Feb; 15(1):93-8. PubMed ID: 10719817 [TBL] [Abstract][Full Text] [Related]
32. Spinal muscular atrophy disrupts the interaction of ZPR1 with the SMN protein. Gangwani L; Mikrut M; Theroux S; Sharma M; Davis RJ Nat Cell Biol; 2001 Apr; 3(4):376-83. PubMed ID: 11283611 [TBL] [Abstract][Full Text] [Related]
33. A direct interaction between the survival motor neuron protein and p53 and its relationship to spinal muscular atrophy. Young PJ; Day PM; Zhou J; Androphy EJ; Morris GE; Lorson CL J Biol Chem; 2002 Jan; 277(4):2852-9. PubMed ID: 11704667 [TBL] [Abstract][Full Text] [Related]
34. Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells. Grzeschik SM; Ganta M; Prior TW; Heavlin WD; Wang CH Ann Neurol; 2005 Aug; 58(2):194-202. PubMed ID: 16049920 [TBL] [Abstract][Full Text] [Related]
35. SMN transcript stability: could modulation of messenger RNA degradation provide a novel therapy for spinal muscular atrophy? Heier CR; Gogliotti RG; DiDonato CJ J Child Neurol; 2007 Aug; 22(8):1013-8. PubMed ID: 17761657 [TBL] [Abstract][Full Text] [Related]
36. Expression of the SMN gene, the spinal muscular atrophy determining gene, in the mammalian central nervous system. Battaglia G; Princivalle A; Forti F; Lizier C; Zeviani M Hum Mol Genet; 1997 Oct; 6(11):1961-71. PubMed ID: 9302277 [TBL] [Abstract][Full Text] [Related]
37. Characterisation of SMN hybrid genes in Spanish SMA patients: de novo, homozygous and compound heterozygous cases. Cuscó I; Barceló MJ; del Rio E; Martín Y; Hernández-Chico C; Bussaglia E; Baiget M; Tizzano EF Hum Genet; 2001 Mar; 108(3):222-9. PubMed ID: 11354634 [TBL] [Abstract][Full Text] [Related]
38. Genetic conversion of an SMN2 gene to SMN1: a novel approach to the treatment of spinal muscular atrophy. DiMatteo D; Callahan S; Kmiec EB Exp Cell Res; 2008 Feb; 314(4):878-86. PubMed ID: 18078930 [TBL] [Abstract][Full Text] [Related]
39. Hybrid survival motor neuron genes in patients with autosomal recessive spinal muscular atrophy: new insights into molecular mechanisms responsible for the disease. Hahnen E; Schönling J; Rudnik-Schöneborn S; Zerres K; Wirth B Am J Hum Genet; 1996 Nov; 59(5):1057-65. PubMed ID: 8900234 [TBL] [Abstract][Full Text] [Related]
40. Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells. Angelozzi C; Borgo F; Tiziano FD; Martella A; Neri G; Brahe C J Med Genet; 2008 Jan; 45(1):29-31. PubMed ID: 17932121 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]